Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HD pharma AB
AB
Active
Org 5594581588
Mörtgränd 8, 175 55
Järfälla
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2023 · 2 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
HD pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
1M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
1 028
Staff expenses
−885
EBITDA
39
Depreciation & amort.
—
EBIT
39
Net financials
−3
Profit before tax
36
Tax
−8
Net profit
28
Balance sheet
SEK thousands
Item
2025
Total assets
231
Equity
53
Long-term debt
—
Short-term debt
178
Total debt
178
Financial ratios
5-year trend
EBITDA margin
3.8%
This company
15.8%
Market median
76% below market
2025
2025
Equity ratio
22.9%
This company
38.2%
Market median
40% below market
2025
2025
Return on equity
52.7%
This company
18.4%
Market median
186% above market
2025
2025
Net profit margin
2.7%
This company
8.1%
Market median
67% below market
2025
2025
Asset turnover
4.46×
This company
1.12×
Market median
298% above market
2025
2025
Debt / equity
3.37×
This company
0.62×
Market median
444% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2023-11-21 – 2025-04-30
View
PDF
More on HD pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
